Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 9th May 2024 CHRS stock ended at $2.12. This is 4.93% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 7.35% from a day low at $2.11 to a day high of $2.27.
90 days $1.91 $2.87
52 weeks $1.44 $5.91

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Jan 03, 2017 $28.55 $28.65 $27.45 $28.00 223 297
Dec 30, 2016 $28.15 $28.40 $27.40 $28.15 185 967
Dec 29, 2016 $28.65 $28.80 $27.95 $28.25 121 103
Dec 28, 2016 $27.95 $29.40 $27.70 $28.55 329 181
Dec 27, 2016 $28.05 $28.70 $27.85 $27.90 205 187
Dec 23, 2016 $28.10 $28.45 $27.95 $28.05 367 100
Dec 22, 2016 $27.95 $28.15 $27.65 $28.00 222 272
Dec 21, 2016 $27.85 $28.15 $27.50 $27.90 181 686
Dec 20, 2016 $28.00 $28.25 $27.70 $27.90 119 111
Dec 19, 2016 $28.35 $28.80 $27.75 $27.80 148 131
Dec 16, 2016 $27.80 $28.95 $27.75 $28.30 831 345
Dec 15, 2016 $27.90 $27.95 $27.50 $27.75 180 650
Dec 14, 2016 $27.60 $28.10 $27.35 $27.80 346 102
Dec 13, 2016 $27.80 $28.15 $27.00 $27.60 222 584
Dec 12, 2016 $28.05 $28.30 $27.35 $27.80 269 247
Dec 09, 2016 $28.00 $28.75 $27.55 $28.15 213 361
Dec 08, 2016 $27.40 $28.05 $27.00 $27.85 242 002
Dec 07, 2016 $27.90 $28.25 $27.05 $27.50 250 427
Dec 06, 2016 $28.35 $28.50 $27.65 $28.15 223 534
Dec 05, 2016 $28.15 $28.85 $28.00 $28.15 213 082
Dec 02, 2016 $27.60 $28.10 $27.15 $27.90 155 660
Dec 01, 2016 $26.90 $28.05 $26.34 $27.55 350 714
Nov 30, 2016 $27.85 $27.85 $26.70 $26.90 393 688
Nov 29, 2016 $27.90 $28.50 $27.65 $27.85 223 665
Nov 28, 2016 $28.25 $28.50 $27.15 $27.80 298 383
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT